Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE

Por Eastell, R., Mitlak, B. H., Wang, Y., Hu, M., Fitzpatrick, L. A., Black, D. M.
Publicado no Osteoporos Int (2019)

Forearm bone mineral density and fracture incidence in postmenopausal women with osteoporosis: results from the ACTIVExtend phase 3 trial

Por Watts, N.B., Dore, R.K., Baim, S., Mitlak, B., Hattersley, G., Wang, Y., Rozental, T.D., LeBoff, M.S.
Publicado no Osteoporos Int (2020)

Tools in the assessment of sarcopenia

Por Cooper, C, Fielding, R, Visser, M, van Loon, LJ, Rolland, Y, Orwoll, E, Reid, K, Boonen, S, Dere, W, Epstein, S, Mitlak, B, Tsouderos, Y, Sayer, AA, Rizzoli, R, Reginster, JY, Kanis, JA
Publicado em 2013

Treatment of osteoporosis in men

Por Kaufman, J.-M., Reginster, J.-Y., Boonen, S., Brandi, M. L., Cooper, C., Dere, W., Devogelaer, J.-P., Diez-Perez, A., Kanis, J. A., McCloskey, E., Mitlak, B., Orwoll, E., Ringe, J.D., Weryha, G., Rizzoli, R.
Publicado em 2012